An intrauterine device (IUD) is a small contraceptive device that is put into the uterus (womb) to prevent pregnancy. The 2 types available in Australia are the copper IUD and the hormonal IUD (MirenaTM). The copper IUD is designed to stay in place for up to 10 years and the hormonal IUD (Mirena) for 5 years. Both can easily be removed sooner, if needed.
Due to the COVID-19 pandemic, the global Intrauterine Devices market size is estimated to be worth US$ 1921.7 million in 2021 and is forecast to a readjusted size of US$ 2359.6 million by 2028 with a CAGR of 2.3% during the review period. Fully considering the economic change by this health crisis, the Europe Intrauterine Devices market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Intrauterine Devices landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Global core intrauterine devices manufacturers include Qualitrol, Mitsubishi Electric and Eaton etc. The top 1 company hold a share about 56%. North America is the largest market, with a share about 65%, followed by Europe and Asia Pacific with the share about 24% and 8%.
This report focuses on Intrauterine Devices volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Intrauterine Devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and India, etc.
Global Intrauterine Devices Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by End User. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Hormonal IUD
Copper IUD
Segment by End User
Age 20-24
Age 25-34
Age 35-44
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Bayer
Merck
Teva Pharmaceutical
Pregna International
Allergan
HRA Pharma
Eurogine
Yantai JiShengYaoXie
TianYi
SMB Corporation
Shenyang Liren
H & J Medical